http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103127497-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103127497-B |
| titleOfInvention | Porcine circovirus 2 type, mycoplasma pneumoniae bivalent inactivated vaccine and preparation method thereof |
| abstract | The invention provides a kind of porcine circovirus 2 type, mycoplasma pneumoniae bivalent inactivated vaccine and preparation method thereof, the porcine circovirus 2 type containing deactivation and the mycoplasma hyopneumoniae of deactivation, vaccine adjuvant and excipient; Wherein, porcine circovirus 2 type content is at least 10n 5.5 tCIDn 50 / head part, mycoplasma hyopneumoniae content is at least 2 × 10n 9 mHDCE/ head part.Bivalent inactivated vaccine of the present invention has following advantage, immune effect all with the commodity list Seedling sum on market quite or better, without interference mutually between two kinds of antigens; Immune duration is long, and effect is lasting; Only need primary immune response, reduce cost, decrease the stress of animal.Bivalent inactivated vaccine of the present invention may be used for preventing Porcine circovirus desease and mycoplasmal pneumonia of swine simultaneously. |
| priorityDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.